Nakashima, Hiroyasu
Ueda, Yuichiro
Miyanari, Yoko
Nishihara, Teruyuki
Hamasaki, Makoto
Ohbu, Makoto
Kawashima, Kenji
Yamakage, Hajime
Miyahara, So
Tokuishi, Keita
Waseda, Ryuichi
Shiraishi, Takeshi
Sato, Toshihiko
Funding for this research was provided by:
Collaborative research between Fukuoka University and Riverfield Inc.
Article History
Received: 26 December 2024
Accepted: 20 March 2025
First Online: 24 March 2025
Declarations
:
: Hiroyasu Nakashima, Yuichiro Ueda, and Toshihiko Sato have received research expenses from Riverfield Inc. Yoko Miyanari, Makoto Hamasaki, Makoto Ohbu, Hajime Yamakage, So Miyahara, Keita Tokuishi, Ryuichi Waseda, and Takeshi Shiraishi have no conflicts of interest or financial ties to disclose. Kenji Kawashima is the founder and stockholder of Riverfield Inc. Teruyuki Nishihara is an employee and stock option holder of Riverfield Inc., which is the manufacturer of the Saroa surgical system used in this study.